对氨基水杨酸衍生物的合成及其抗结核活性的研究进展
作者：刘文;张金坤;范莉;杨大成;
Author：
收稿日期： 年卷（期）页码：2016,31(06):-663-667
期刊名称：华西药学杂志
Journal Name：WEST CHINA JOURNAL OF PHARMACEUTICAL SCIENCES
关键字：对氨基水杨酸;衍生物;合成;结核;抗结核活性;抑制剂;研究概况;综述
Key words：
基金项目：国家自然科学基金应急项目(项目编号:21542003);;
西南大学国家级大学生创新训练计划(项目编号:201510635001)
中文摘要
对氨基水杨酸是著名的多官能团抗结核的治疗药物。对氨基水杨酸的衍生化既着眼于氨基、羧基及羟基的衍生,同时也进行了苯环上的取代。文中综述了对氨基水杨酸衍生物的合成及其抗结核活性的研究进展。
参考文献
[1]Lehmann J.P-Aminosalicylic acid in the treatment of tuberculosis[J].Lancet,1946,250:15-16.
[2]Nakao M.Studies on the metabolism of para-aminosalicylic acid:I.Paper chromatographic analysis of human urine[J].J Biochem,1957,44(6):327-335.
[3]Nakao M,Yanagisawa I.Studies on the metabolism of paraaminosalicylic acid:Ⅱ.Characterization of glucuronides in human urine after administration of para-aminosalicylate[J].J Biochem,1957,44(7):433-441.
[4]Nakao M,Yanagisawa I,Yoshikawa H.Studies on the metabolism of para-aminosalicylic acid:Ⅲ.A comparative study among different kinds of mammals[J].J Biochem,1957,44(8):477-480.
[5]Youmans GP,Raleigh GW,Youmans AS.The tuberculostatic action of para-aminosalicylic acid[J].J Bacteriol,1947,54(4):409-416.
[6]Hedgecock LW.Mechanisms involved in the resistance of mycobacterium tuberculosis to para-aminosalicylic acid[J].J Bacteriol,1958,75(3):345-350.
[7]Hedgecock LW.Antagonism of methionine in aminosalicylateinhibition of Mycobacterium tuberculosis[J].J Bacteriol,1958,75(4):417-421.
[8]Kakemi K,Arita T,Kitazawa S,et al.Studies on the pharmaceutical potentiation of drugs.I.p-Aminosalicylic acid derivatives[J].Chem Pharm Bull,1967,15(12):1819-1827.
[9]Chanker LS,Tocco DJ,Brodie BB,et al.Absorption of drugs from the rat small intestine[J].J Pharmacol Exp Ther,1958,123(1):81-88.
[10]Brodie BB,Hogben CAM.Some physicochemical factors in drug action[J].J Pharm Pharmacol,1957,9(6):345-380.
[11]Klotz IM.Non-covalent bonds in protein structure[J].Brookhaven Symp Biol,1960,13(13):25-48.
[12]Giacomino A,Abollino O,Malandrino M,et al.The interactions of drugs and plasma proteins[J].J Pharmacol Exp Ther,2012,54(4):685-697.
[13]Vergne AF,Walz AJ,Miller MJ.Iron chelators from mycobacteria(1954-1999)and potential therapeutic applications[J].Nat Prod Rep,2000,17(1):99-116.
[14]Jensen KA,Rosdahl KG,Ingvorsen H.Tuberculostatic derivatives of p-aminobenzoic acid.I.Esters and amides of 4-aminosalicylic acid[J].Acta Chem Scand,1948,2(2):220-224.
[15]Doub L,Schaefer JJ,Bambas LL,et al.Some derivatives of 4-amino-2-hydroxybenzoic acid(p-aminosalicylic acid)[J].JAm Chem Soc,1951,73(3):903-906.
[16]Kakemi K,Arita T,Kitazawa S,et al.Studies on the pharmaceutical potentiation of drugs.II.p-aminosalicylic acid derivatives[J].Chem Pharm Bull,1967,15(12):1828-1840.
[17]Kakemi K,Sezaki H,Kitazawa S.Studies on the pharmaceutical potentiation of drugs.III.Antagonistic effects of PABA on antitubercular activities of PAS derivatives[J].Chem Pharm Bull,1967,15(7):925-931.
[18]Rawat J,Jain PK,Ravichandran V,et al.Synthesis and evaluation of mutual prodrugs of isoniazid,p-amino salicylic acid and ethambutol[J].Arkivoc Arch Org Chem,2007,40:105-118.
[19]Shavel J,Leonard F,Mcmillan FH,et al.Antitubercular substances.I.Alkyl,aralkyl,aryl,and cyclic hydrazides and miscellaneous nitrogenous derivatives[J].J Am Pharm Assoc,1953,42(7):402-407.
[20]Esfahanizadeh M,Omidi K,Kauffman J,et al.Synthesis and evaluation of new fluorinated antitubercular compounds[J].Iran JPharm Res,2014,13(1):115-126.
[21]Kobarfard F,Kauffman JM.Halogenated antituberculosis agents[P].US:6482982,2002-11-21.
[22]Bhate DS,Panse TB,Venkataraman K.Antitubercular compounds.Ⅱ.3,5-Diiodo-4-aminosalicylic acid,4-aminoO-acetylsalicylic acid and other derivatives of 4-aminosalicylic acid[J].Proc Ind Acad Sci,Sec A,1950,32(6):357-366.
[23]Kumar S,Dhar DN,Saxena PN.Applications of metal complexes of Schiff bases-A review[J].J Sci Ind Res,2009,68(3):181-187.
[24]Patole J,Shingnapurkar D,Padhye S,et al.Schiff base conjugates of p-aminosalicylic acid as antimycobacterial agents[J].Bioorg Med Chem Lett,2006,16(6):1514-1517.
[25]Ales I,Slovenko P,Jarmila V,et al.A new modification of antitubercular active molecules[J].Bioorg Med Chem,2007,15(7):2551-2559.
[26]Eswaran S,Adhikari AN.Design and synthesis of some new quinoline-3-carbohydrazone derivatives as potential antimycobacterial agents[J].Bioorg Med Chem Lett,2010,20(3):1040-1044.
[27]Vinsova J,Imramovsky A,Jampilek J,et al.Recent advances on isoniazide derivatives[J].Anti-Infect Agents Med Chem,2008,7(7):12-31.
[28]Amit N,Alpeshkumar M,Evans C,et al.Synthesis,antituberculosis activity,and 3D-QSAR study of ring-substituted-2/4-quinolinecarbaldehyde derivatives[J].Bioorg Med Chem,2006,14(21):7302-7310.
[29]Pelttari E,Karhumki E,Langshaw J,et al.Carbohydrazones of substituted salicylaldehydes as potential lead compounds for the development of narrow-spectrum antimicrobials[J].Z Naturforsch C,2007,62:483-486.
[30]Vavrikova E,Polanc S,Kocevar M,et al.New fluorine-containing hydrazones active against MDR-tuberculosis[J].Eur J Med Chem,2011,46(10):4937-4945.
[31]Hirt R,Hurni H.Die tuberkulostatische Wirkung von paminosalicylsure-Derivaten undhnlichen Substanzen[J].Helv Chim Acta,1949,32(2):378-393.
[32]Foye WO,Hull RL.Amino acid derivatives of aminosalicylic acids[J].J Am Pharm Assoc,1953,42(1):50-53.
[33]Polglase WJ,Darrach M.The enzymatic hydrolysis of some nsubstituted derivatives of para-aminosalicylic acid in vivo and in vitro[J].Fed Proc,1959,18(1):303-303.
[34]Makki MSIT,Abdel-Rahman RM,Faidallah HM,et al.Synthesis of new fluorine substituted heterocyclic nitrogen systems derived from p-aminosalicylic acid as antimycobacterial agents[J].JChem,2013,2013:1-8.
【关闭】
